Event programme

ETPN2026 at a glance

```html
ETPN2026 Conference Booklet cover
Conference booklet

Download the ETPN2026 Conference Booklet

The full ETPN2026 booklet includes the programme, speakers, sessions, abstracts, sponsors and practical information for the conference.

Detailed time schedule

Wednesday, June 17 Day 1
Wednesday, June 17

Day 1

Registration
ETPN members Academy participants

Arrival & check-in

Badge collection and arrival for the opening morning of ETPN2026.

08:30–09:30
RCSI Dublin
ETPN General Assembly
For ETPN members

Activity & financial reports

The statutory opening block of the General Assembly, focused on core reporting and essential member information in a concise and structured format.

Venue: Desmond Auditorium

Session chair: Lorena Diéguez, ETPN Vice-Chair; Group Leader, INL, Portugal
View details

This part of the General Assembly is reserved for ETPN members.

ETPN Academy · Session 1
Students & early-career researchers

Building a Nanomedicine Story

Choices, risks and lessons learned with Laurent Lévy, followed by a short scientific talk on mRNA-LNP engineering of human T cells.

Venue: Houston Lecture Theatre

Session lead: Marco Monopoli, Senior Lecturer, RCSI University of Medicine and Health Sciences, Ireland; ETPN Working Group Leader, Education & Training
Explore the session

The ETPN Academy is a dedicated morning format for PhD students, early-stage researchers and young professionals, built to give participants direct access to senior leaders, entrepreneurs and technology experts in a more informal and practical format than a standard scientific session.

In this first session, Laurent Lévy will share lessons from the development of a nanomedicine company and reflect on the scientific, strategic, entrepreneurial and clinical choices that shape the translation of an advanced technology towards patients.

The session will also include a short 20-minute scientific contribution by Sergio Garrido Areal on non-viral engineering of human T cells using immunomodulatory mRNA lipid nanoparticles.

Main Academy speaker
Laurent Lévy
ETPN Chair; CEO, Nanobiotix, France
Academy conversationBuilding a Nanomedicine Story: Choices, Risks and Lessons Learned
Short Academy talk
Sergio Garrido Areal
University of Santiago de Compostela, Spain
Short scientific talkNon-viral engineering of human T cells using immunomodulatory mRNA lipid nanoparticles
09:30–11:00
RCSI Main Building, St Stephen’s Green campus
Coffee break
11:00–11:30
RCSI Main Building, St Stephen’s Green campus
ETPN General Assembly
For ETPN members

Members’ interactive forum

A shorter, discussion-oriented member block designed to keep the General Assembly useful, focused and genuinely member-facing.

Venue: Desmond Auditorium

Session chair: Laurent Lévy, ETPN Chair; CEO, Nanobiotix, France
View details

This part of the General Assembly is reserved for ETPN members.

ETPN Academy · Session 2
Students & early-career researchers

Practical Technology Insights

Formulation, particle analysis and characterisation with Inside Therapeutics, SPARTA Biodiscovery and Postnova Analytics.

Venue: Houston Lecture Theatre

Session lead: Marco Monopoli, Senior Lecturer, RCSI University of Medicine and Health Sciences, Ireland; ETPN Working Group Leader, Education & Training
View contributors and topics

The second Academy session gives participants direct access to three ETPN sponsors and industry members through short, practical and didactic contributions. The format remains informal, interactive and educational, with a strong focus on practical understanding rather than commercial presentation.

Contributors
Sezen Gul Inside Therapeutics Practical aspects of microfluidics and RNA-LNP formulation, including process parameters, scalability and critical quality attributes
Ben Peacock SPARTA Biodiscovery Advanced particle and nanoparticle analysis, what SPARTA can reveal, and interpretation mistakes to avoid
Florian Meier Postnova Analytics The basics of FFF / AF4 and multi-detector characterisation for complex nano- and biopharmaceutical samples
11:30–13:00
RCSI Main Building, St Stephen’s Green campus
Lunch break & networking
13:00–14:00
Exam Hall, RCSI Dublin
Poster Symposium
Open to all ETPN2026 attendees

ETPN2026 Poster Symposium

The event opens to all attendees with a dedicated poster-focused block designed to trigger early interaction, visibility and scientific exchange across the community.

View details

Posters will receive dedicated visibility during this session, in addition to standard networking and break moments.

14:00–16:00
Exam Hall, RCSI Dublin
Coffee break
16:00–16:30
Exam Hall, RCSI Dublin
16:30–16:45
Desmond Auditorium, RCSI Dublin
Strategic opening
Open to all ETPN2026 attendees

Welcome + FP10 / Policy Strategic Opening

A strategic opening discussion to connect ETPN2026 with the future European research and innovation framework, and to frame how nanomedicine, advanced materials and HealthTech can remain visible, clinically relevant and translation-ready in FP10.

Meet the opening contributors
Welcoming by RCSI Professor Fergal O’Brien Deputy Vice Chancellor for Research & Innovation; Professor of Bioengineering & Regenerative Medicine, RCSI University of Medicine and Health Sciences Marco Monopoli RCSI University of Medicine and Health Sciences
Welcome by ETPN Chair and Vice-Chairs Laurent Lévy ETPN Chair Lorena Diéguez ETPN Vice-Chair Furio Gramatica ETPN Vice-Chair
Strategic contribution Laurent Lévy Title to be confirmed
Strategic contribution Lorena Diéguez Nanomedicine in FP10
Programme / logistics framing and transition to the opening keynote Alexandre Ceccaldi ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
16:45–17:30
Desmond Auditorium, RCSI Dublin
Opening keynote
Open to all ETPN2026 attendees
Professor Kenneth A. Dawson
Professor Kenneth A. Dawson
Chair of Physical Chemistry, School of Chemistry, University College Dublin; Director, Centre for BioNano Interactions (CBNI)
Keynote lectureA new grammar of Bionanoscale interactions, and potential role in advanced therapeutics

The first keynote of ETPN2026 closes Day 1 with a fundamental and forward-looking perspective on how nanostructures interact with living systems, and what this may unlock for advanced therapeutics.

Discover Kenneth Dawson’s keynote

Professor Kenneth A. Dawson is Director of the Centre for BioNano Interactions (CBNI) at University College Dublin. His scientific work focuses on understanding how nanostructures interact with living systems, and he pioneered the biomolecular, or protein, corona concept, which became a central paradigm in the field.

His research aims to obtain a mechanistic and molecular understanding of nanoscale recognition in biology. His most recent work explores how fundamental insights at the nanoscale interface may help enable escape from endosomes and reach therapeutically inaccessible locations.

17:30–18:30
Desmond Auditorium, RCSI Dublin
18:30–20:00
RCSI 118 Terrace
Thursday, June 18 Day 2
Thursday, June 18

Day 2

Clinical needs

Clinical Needs / Unmet Clinical Needs in Nanomedicine

This moderated panel will bring clinical perspectives into direct discussion with the nanomedicine and health technology community. Contributors will highlight real unmet needs, patient relevance, clinical adoption challenges and the practical conditions required for advanced technologies to become genuinely useful in care.

Session chair: Marco Monopoli, Senior Lecturer, RCSI University of Medicine and Health Sciences, Ireland; ETPN Working Group Leader, Education & Training
Moderator: Alexandre Ceccaldi, PhD, ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
Explore this clinical-needs panel
Session chair Dr Marco Monopoli Senior Lecturer, RCSI University of Medicine and Health Sciences, Ireland; ETPN Working Group Leader, Education & Training
Moderator Dr Alexandre Ceccaldi ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
Confirmed contributors so far Dr Andrea Piccin Consultant Haematologist, Mater Hospital / Mater Private, Dublin Dr Aamir Hameed Cardiologist and Clinical Researcher, RCSI University of Medicine and Health Sciences Professor Sabine A. Fuchs Professor of Metabolic Diseases and Innovative Therapies, Wilhelmina Children’s Hospital / UMC Utrecht — joining remotely by Teams Prof. Leonie Young Endocrine Oncology Research Group, RCSI University of Medicine and Health Sciences
09:00–10:15
Desmond Auditorium, RCSI Dublin
Coffee break
Sponsored byAccelopment logo
10:15–11:00
Exam Hall, RCSI Dublin
[DEVICES]

Nano-enabled Medical Devices, Diagnostics & Clinical Decision Support

A core scientific session focused on the interface between nanomedicine, diagnostics, devices and clinically actionable technologies, with strong translational and implementation relevance.

Session chair: Lorena Diéguez, ETPN Vice-Chair; Group Leader, INL – International Iberian Nanotechnology Laboratory, Portugal
View speaker & talk line-up
Dr Paul Galvin
Invited speaker
Dr Paul Galvin
Tyndall National Institute, Ireland
Invited talkScaling digital healthtech from bench to bedside

Dr Paul Galvin is Senior Head of Groups for Bioelectronics, Head of the Life Sciences Interface Group, Head of ICT for Health Strategic Programmes and Director of the ENTIRE European Digital Innovation Hub at Tyndall National Institute in Cork, Ireland. Working with clinical scientists and the digital healthtech industry, he has led multidisciplinary national and international digital healthtech research projects leveraging deep tech, nano and semiconductor-enabled solutions to address diagnostic and therapeutic challenges in healthcare.

Detailed running order
11:30–12:00 — Dr Paul Galvin Tyndall National Institute, Ireland Scaling digital healthtech from bench to bedside
12:00–12:15 — Valentina Mangolini IRCCS Fondazione Don Carlo Gnocchi, Italy Toward non-invasive stratification of neurodegenerative disorders through Raman analysis of salivary extracellular vesicles
12:15–12:30 — Giulia Tomaino University of Milano-Bicocca, NanoBioLab, Italy Reprogramming the Pancreatic Adenocarcinoma Microenvironment integrating mutSEMA3A mRNA-Lipid Nanoparticles with a Vascularized Organ-on-Chip Model
12:30–12:45 — Luana Forleo IRCCS Fondazione Don Carlo Gnocchi ETS, Italy Circulating nanoparticles as biomarkers of brain regeneration processes after stroke
12:45–12:53 — Erica Quagliarini Sapienza University of Rome, Italy Bio-nano Interactions in Emerging Precision Nanomedicine
12:53–13:00 — Teresa Valero GENYO - Nanochembio, Spain Hybrid Mass-Tag Fluorescent Nanotrackers for Long-Term Live-Cell Barcoding and Multiplexed Phenotypic Drug Screening
11:00–13:00
Desmond Auditorium, RCSI Dublin
EU Project Spotlight

SENSOPAD

A concise EU project spotlight integrated after the DEVICES session, highlighting the SENSOPAD project and its approach to portable sensing for endometriosis.

View project spotlight
Spotlight talk
13:00–13:15 — Lorena Diéguez INL, Portugal SENSOPAD: Sensing ENdometriosiS On Portable Auxiliary Devices
13:00–13:15
Desmond Auditorium, RCSI Dublin
Lunch break & networking
13:15–14:30
Exam Hall, RCSI Dublin
[TRANSLATION]

Scale-up, Manufacturing, Regulation & Translational Complexity

One of the structural sessions of ETPN2026, this block addresses the real bottlenecks that often determine whether promising nanomedicine innovation can actually reach patients.

Session chair: Alexandre Ceccaldi, PhD, ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
View speaker & talk line-up
Olivia Lewis
Invited speaker
Olivia Lewis
Utrecht University, Netherlands; NANOSPRESSO-NL
Invited talkThe Silent Carrier? Regulatory Recognition and Management of Lipid Nanoparticle-Associated Risks in EU-Authorised Medicinal Products

Olivia Lewis is a PhD candidate in Drug Regulatory Science at Utrecht University and part of the NANOSPRESSO-NL project. Her research focuses on regulatory challenges related to nucleic acid therapeutics, lipid-based nanoparticle delivery systems and decentralised manufacturing approaches for personalised medicines. Her work connects regulatory science, translational medicine and the societal implementation of innovative therapies.

Detailed running order
14:30–15:00 — Olivia Lewis Utrecht University, Netherlands; NANOSPRESSO-NL The Silent Carrier? Regulatory Recognition and Management of Lipid Nanoparticle-Associated Risks in EU-Authorised Medicinal Products
15:00–15:15 — Lucía Sanjurjo Bouza Universidade de Santiago de Compostela, Spain Translating microfluidic RNA nanocarriers into a ready-to-use transfection reagent for primary cells
15:15–15:30 — Elena-Marie Willner Postnova Analytics, Germany Multi-detector Field-Flow Fractionation for the assessment of critical quality attributes of Adeno-Associated Viruses (AAVs)
15:30–15:45 — Lorna FitzPatrick Medicines Discovery Catapult Ltd, United Kingdom Accelerating translational readiness of nanomedicines through integrated analytical platforms and regulatory engagement
15:45–15:53 — Jakob Nassauer Fraunhofer IMM, Germany Bidirectional scalable microfluidic formulation platform for the reliable production of mRNA nanotherapeutics
15:53–16:00 — Chair synthesis / buffer / transition Session transition Short synthesis and transition to sponsor spotlight.
14:30–16:00
Desmond Auditorium, RCSI Dublin
16:00–16:15
Desmond Auditorium, RCSI Dublin
Coffee break
Sponsored byAccelopment logo
16:15–17:00
Exam Hall, RCSI Dublin
[PITCH]

Pitch Me Up!

A dynamic, innovation-oriented format designed to give visibility to translational projects, emerging companies and innovation-driven initiatives with strong application potential.

Session chair: Laurent Lévy, ETPN Chair; CEO, Nanobiotix, France
View pitch presentations

This session is intended to be punchier and more entrepreneurial in rhythm, while remaining fully aligned with the scientific and translational identity of the event.

Detailed running order
17:00–17:15 — Nan Zhang University College Dublin, Ireland High-Throughput Parallel Aerofoil-Based Microfluidics for Cost-Effective Screening and AI-Driven Optimization of Lipid Nanoparticles for Nanomedicine
17:15–17:30 — Monica Lopez Fanarraga Universidad de Cantabria - IDIVAL, Spain Reversible DNA-Silica Encapsulation Platform: A Scalable Solution for Storage, Delivery and Oral DNA Vaccination in Nanomedicine
17:30–17:45 — Niall Byrne Queen's University of Belfast / BXTA Nanotherapy Ltd, United Kingdom AuX2R: An innovative chemokine-directed gold nanoparticle for dual radiotherapy enhancement in prostate cancer
17:00–17:45
Desmond Auditorium, RCSI Dublin
Day 2 keynote
Professor Raymond Schiffelers
Professor Raymond Schiffelers
Professor of Nanomedicine, University Medical Center Utrecht, Netherlands; Former ETPN Chair; Vice President, Preclinical R&D, NanoCell
Keynote lectureNucleic acid nanomedicines: design rules and surprises

The second keynote of ETPN2026 will bring a high-level scientific and translational perspective on nucleic acid nanomedicines, RNA/LNP therapeutics, delivery design and the evolving path from platform development to clinical impact.

Explore Raymond Schiffelers’ keynote

Professor Raymond Schiffelers is Professor of Nanomedicine at the University Medical Center Utrecht, where his work focuses on synthetic drug delivery systems, RNA delivery and extracellular vesicles as inspiration for new therapeutic and diagnostic approaches. Trained in Bio-Pharmaceutical Sciences at Leiden University, he obtained his PhD at Erasmus University Rotterdam on liposomal targeting of antimicrobial agents, before working on liposome- and polymer-based delivery systems for tumour vasculature targeting and siRNA delivery in Utrecht and in the US. He has contributed extensively to the development of nanomedicine platforms for diagnosis and therapy, has co-founded and advised several start-ups, and served as Chair of the European Technology Platform on Nanomedicine from 2021 to 2025.

17:45–18:45
Desmond Auditorium, RCSI Dublin
20:00–00:30
The Cellar, The Church, Dublin
Friday, June 19 Day 3
Friday, June 19

Day 3

[EU-PROJ]

European Projects in Nanomedicine

The final day opens with a compact European-facing block giving visibility to current collaborative initiatives, project dynamics and concrete examples of nanomedicine activity across Europe.

Session chair: Furio Gramatica, ETPN Vice-Chair; Director, Development and Innovation, Fondazione Don Carlo Gnocchi, Italy
View project talks

This session is designed to keep a strong European and coordination-oriented tone at the start of Day 3.

Detailed running order
09:15–09:30 — Lavinia Rita Doveri University of Pavia, Italy From nano to bulk: multiscale characterization of chemical homogeneity in functional nanomaterials
09:30–09:45 — Caterina Minelli National Physical Laboratory, United Kingdom Advances and translation of chemical spectroscopy methods for lipid-based particles
09:45–10:00 — Valentina Cauda Politecnico di Torino, Italy Rational Design of bio-inspired nanoparticles for cancer treatment as on-demand triggerable nanotheranostics
09:15–10:00
Desmond Auditorium, RCSI Dublin
[BROKERAGE]

Upcoming Funding Opportunities for Nanomedicine

A compact brokerage session to support new European collaborations, project ideas and upcoming funding opportunities in nanomedicine and related health technologies.

Session chair: Alexandre Ceccaldi, PhD, ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
Explore this session
Invited speaker
Alexandre Ceccaldi
PhD, ETPN General Secretary; ETPN2026 Event Coordinator; Chair of the ERA4Health Strategic Advisory Board
10:00–11:00
Desmond Auditorium, RCSI Dublin
Coffee break
11:00–11:30
Desmond foyer, RCSI Dublin
[REGEN]

Regenerative Medicine & Advanced Therapeutic Interfaces

This scientific block highlights regenerative approaches, advanced interfaces and next-generation therapeutic concepts at the boundary of nanomedicine and broader HealthTech innovation.

Session chair: Ester Canepa, PhD, Research Scientist, Centre for BioNano Interactions, University College Dublin, Ireland
View speaker & talk line-up
Professor Fergal O’Brien
Invited speaker
Professor Fergal O’Brien
RCSI University of Medicine and Health Sciences, Ireland
Invited talkBiomaterial scaffolds for the delivery of nanomedicines for enhanced tissue repair

Professor Fergal O’Brien is Deputy Vice Chancellor for Research and Innovation, Professor of Bioengineering and Regenerative Medicine, and Head of the Tissue Engineering Research Group at RCSI. He is a leading innovator in advanced biomaterials and medical devices for tissue repair, with particular interest in scaffold-based delivery of nanomedicines for enhanced regeneration. His work spans publications, patents, doctoral supervision, spin-out activity and clinical translation of regenerative technologies.

Detailed running order
11:30–12:00 — Professor Fergal O’Brien RCSI University of Medicine and Health Sciences, Ireland Biomaterial scaffolds for the delivery of nanomedicines for enhanced tissue repair
12:00–12:15 — Nathalie Barroca University of Aveiro, Portugal A 3D Platform for Electrical Stimulation of Neural Stem Cells Using Graphene Electrodes
12:15–12:30 — Francesco Schiavone Politecnico di Torino, Italy Advanced hybrid nanoparticles for targeted microRNA-mediated cardiac reprogramming
12:30–12:45 — Owen Davies Loughborough University, United Kingdom Matrix Vesicles as a Potent Therapeutic for Hard Tissue Regeneration
12:45–12:55 — Sofia Bonsignore University of Palermo, Italy Zein-Based Lipid-Polymer Hybrid Nanocarriers for Inhaled siRNA Delivery by Nebulization
12:55–13:00 — Chair wrap-up / transition to lunch Session transition Short wrap-up and transition to lunch.
11:30–13:00
Desmond Auditorium, RCSI Dublin
Light lunch
13:00–13:45
Exam Hall, RCSI Dublin
[EMERGING]

Emerging Therapies, Precision Nanomedicine & Advanced Drug Delivery

The final flagship therapeutic session of ETPN2026 closes the scientific programme with a forward-looking focus on advanced delivery strategies, precision approaches and emerging therapeutic modalities.

Session chair: Andreas Åslund, Researcher, SINTEF, Norway
View speaker & talk line-up
Sergio Moya
Invited speaker / invited framing talk
Sergio Moya
Soft Matter Nanotechnology, CIC biomaGUNE, Spain
Invited talkIn Vivo Fate, Targeting, and Protein Corona Formation in Nanocarrier Design for Drug Delivery

Sergio Moya studied Chemistry at the University of the South, Argentina, and obtained his PhD while working at the Max Planck Institute of Colloids and Interfaces, Germany. He subsequently carried out postdoctoral research at the Collège de France and the University of Cambridge. Since 2007, he has been a group leader at CIC biomaGUNE, Spain. His research interests span physical chemistry, materials science and nanomedicine.

Detailed running order
13:45–14:15 — Sergio Moya CIC biomaGUNE, Spain In Vivo Fate, Targeting, and Protein Corona Formation in Nanocarrier Design for Drug Delivery
14:15–14:30 — Rosario M. Sanchez-Martin University of Granada - GENYO & Faculty of Pharmacy, Spain A Dual-Functional Tracker Nanocatalyst for Real-Time Intracellular Screening and Optimization of Bioorthogonal Click Chemistry
14:30–14:45 — Marion Le Meur IMDEA Nanociencia, Spain Encapsulation of circadian clock-modulating molecule into brain-targeted nanoparticles for Alzheimer's disease
14:45–15:00 — Stephanie Annett RCSI, Ireland An mRNA Based Therapy for Obesity: Targeting Metabolic Regulation Beyond Appetite Suppression
15:00–15:08 — Lucia Salvioni University of Milano-Bicocca, NanoBioLab, Italy Protease-Resistant Mirror-Image Peptide Nanoparticles for Enhanced Macrophage-Targeted Nucleic Acid Delivery
15:08–15:15 — Núria Basanta Pons Institut Català de Nanociència i Nanotecnologia, ICN2, Spain Intranasal Administration of Neuromelanin-like Bioinspired Nanoparticles for Glioblastoma Treatment
13:45–15:15
Desmond Auditorium, RCSI Dublin
Short break / voting consolidation
15:15–15:30
Desmond foyer, RCSI Dublin
Awards & closing

Awards + Best Talks & Best Posters + Closing Remarks

The event concludes with final recognition moments, including the Best Talks and Best Posters awards sponsored by SSPC, closing remarks and a short wrap-up designed to end the meeting with clarity, appreciation and momentum for what comes next.

Session leads: Marco Monopoli & Alexandre Ceccaldi, ETPN2026 Organising Committee
View details

Awards and closing remarks, including Best Talks and Best Posters recognition sponsored by SSPC, and final wrap-up of ETPN2026.

Closing remarks
Marco Monopoli & Alexandre Ceccaldi
ETPN2026 Organising Committee
15:30–16:00
Desmond Auditorium, RCSI Dublin

Registration

ETPN2026 is open to all: students, researchers, engineers, clinicians, SMEs, industry, institutions. Join us in Dublin next June and seize the opportunity to connect with pioneers in nanomedicine and MedTech, enriching your professional network and knowledge. Dive into interactive sessions designed to spark innovation and collaboration in the vibrant field of nanomedicine, advanced materials & emerging healthtech.

Subscribe for updates

Join the ETPN2026 community and stay updated on the conference. Subscribe for exclusive news and insights that keep you ahead. Don’t miss your chance to connect with innovators and explore new opportunities in healthcare.

ETPN2026 Dublin | 21st Annual Event of ETPN

ETPN2026 Dublin is the 21st Annual Event of the European Technology Platform on Nanomedicine, hosted by RCSI in Dublin from 17 to 19 June 2026. A lean, fully in-person edition focused on science, translation, collaboration and community building

Contact

contact@etpn2026.eu

ETPN Association

64-66 rue des archives 75003 Paris, FRANCE

© 2026 ETPN2026. All rights reserved.